Related Experiment Video

Updated: Jul 19, 2025

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.9K

Challenges in proliferative vitreoretinopathy: is biological therapy a solution?

Lorenzo Ferro Desideri1,2,3, Souska Zandi1,2,3, Martin S Zinkernagel1,2,3

  • 1Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Expert Opinion on Biological Therapy
|August 15, 2023
PubMed
Summary

No abstract available in PubMed .

Keywords:
PVRPVR classificationProliferative vitreoretinopathycorticosteroidsmethotrexatetherapeutic challenges

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.4K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

6.7K

Related Experiment Videos

Last Updated: Jul 19, 2025

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.9K
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.4K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

6.7K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

479
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
479

Articles linked to this work by shared authors, journal, and citation graph.

Clinical variations and outcomes of central serous chorioretinopathy in Black and White patients: MICRoN report-16.

Retina (Philadelphia, Pa.)·2026

ACUTE MACULAR NEURORETINOPATHY-LIKE LESIONS AS AN OCT-DEFINED PHENOTYPE: A SPECTRUM FROM ISCHEMIA TO INFLAMMATION.

Retina (Philadelphia, Pa.)·2026

Hispanic versus non-Hispanic patients with Central Serous Chorioretinopathy: MICRoN report 18.

Retina (Philadelphia, Pa.)·2026

High Frequency of Paracentral Acute Middle Maculopathy among symptomatic post-cardiac surgery patients.

Retina (Philadelphia, Pa.)·2026

Influence of smoking on the human ocular surface microbiome and tear proteome.

Scientific reports·2026

Monitoring of Geographic Atrophy Progression in Age-Related Macular Degeneration Using Fluorescence Lifetime Imaging Ophthalmoscopy.

Investigative ophthalmology & visual science·2026

Originator versus biosimilar adalimumab in hidradenitis suppurativa: a real-world cohort study.

Expert opinion on biological therapy·2026

Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study.

Expert opinion on biological therapy·2026

Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.

Expert opinion on biological therapy·2026

Gene therapy approaches for inborn errors of immunity: from bench to bedside.

Expert opinion on biological therapy·2026

Dual REmission in moderate-to-severe AsthMa and Nasal Polyps: a multicentric observational Phase IV real-life study (DREAM-NP).

Expert opinion on biological therapy·2026

Breaking immune exclusion in cold tumors via TGF-β pathway inhibition.

Expert opinion on biological therapy·2026

Effects of Propranolol, Metoprolol, and Nebivolol on isolated rat atrial preparations and thoracic aorta: Involvement of nitric oxide in nebivolol-induced negative chronotropic and inotropic responses.

Physiology international·2026

Quality management and specifications of multidisciplinary Parkinson's disease management: an expert opinion.

Journal of neural transmission (Vienna, Austria : 1996)·2026

[Measurement of platelet enzymatic activities in assessing the clinical response to antipsychotic therapy in patients with late-onset schizophrenia-like psychoses].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

Principles of selecting cost-effectiveness thresholds in price-taker countries.

Expert review of pharmacoeconomics & outcomes research·2026

Spinal and bulbar muscular atrophy in a patient with Parkinson's disease - Case report.

Clinical parkinsonism & related disorders·2026

Euonymus alatus in diabetes: a review of phytochemistry, pharmacokinetics, and anti-diabetic mechanisms.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us